Celyad Oncology SA (CLYYF)
0.30
0.00 (0.00%)
USD |
OTCM |
Jun 12, 16:00
Celyad Oncology Total Assets (Quarterly): 13.23M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 13.23M |
| June 30, 2022 | 65.96M |
| March 31, 2022 | 77.25M |
| December 31, 2021 | 90.51M |
| September 30, 2021 | 67.50M |
| June 30, 2021 | 74.60M |
| March 31, 2021 | 72.80M |
| December 31, 2020 | 81.28M |
| June 30, 2020 | 85.20M |
| December 31, 2019 | 100.63M |
| June 30, 2019 | 92.50M |
| June 30, 2019 | 92.50M |
| December 31, 2018 | 107.87M |
| June 30, 2018 | 126.09M |
| June 30, 2018 | 126.09M |
| December 31, 2017 | 93.13M |
| Date | Value |
|---|---|
| June 30, 2017 | 137.61M |
| June 30, 2017 | 137.61M |
| December 31, 2016 | 146.74M |
| June 30, 2016 | 155.72M |
| June 30, 2016 | 155.72M |
| December 31, 2015 | 174.41M |
| June 30, 2015 | 205.59M |
| June 30, 2015 | 205.59M |
| December 31, 2014 | 53.48M |
| June 30, 2014 | 70.68M |
| June 30, 2014 | 70.68M |
| December 31, 2013 | 44.72M |
| June 30, 2013 | 19.61M |
| June 30, 2013 | 19.61M |
| December 31, 2012 | 16.51M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
13.23M
Minimum
Jun 2023
100.63M
Maximum
Dec 2019
76.17M
Average
79.27M
Median
Total Assets (Quarterly) Benchmarks
| Galapagos NV | 4.710B |
| UCB SA | 17.18B |
| Mithra Pharmaceuticals SA | 407.25M |
| Nyxoah SA | 122.05M |
| MDxHealth SA | 121.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.13M |
| Shareholders Equity (Quarterly) | 1.107M |
| Current Ratio | 1.263 |
| Net Debt Paydown Yield | 1.18% |